These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 18161868

  • 1. Concurrent administration of zoledronic acid and irradiation leads to improved bone density, biomechanical strength, and microarchitecture in a mouse model of tumor-induced osteolysis.
    Arrington SA, Damron TA, Mann KA, Allen MJ.
    J Surg Oncol; 2008 Mar 01; 97(3):284-90. PubMed ID: 18161868
    [Abstract] [Full Text] [Related]

  • 2. Anabolic and antiresorptive drugs improve trabecular microarchitecture and reduce fracture risk following radiation therapy.
    Arrington SA, Fisher ER, Willick GE, Mann KA, Allen MJ.
    Calcif Tissue Int; 2010 Sep 01; 87(3):263-72. PubMed ID: 20563797
    [Abstract] [Full Text] [Related]

  • 3. Optimal timing of a single dose of zoledronic acid to increase strength in rat fracture repair.
    Amanat N, McDonald M, Godfrey C, Bilston L, Little D.
    J Bone Miner Res; 2007 Jun 01; 22(6):867-76. PubMed ID: 17371160
    [Abstract] [Full Text] [Related]

  • 4. Bolus or weekly zoledronic acid administration does not delay endochondral fracture repair but weekly dosing enhances delays in hard callus remodeling.
    McDonald MM, Dulai S, Godfrey C, Amanat N, Sztynda T, Little DG.
    Bone; 2008 Oct 01; 43(4):653-62. PubMed ID: 18582604
    [Abstract] [Full Text] [Related]

  • 5. Skeletal remodeling following clinically relevant radiation-induced bone damage treated with zoledronic acid.
    Hui SK, Fairchild GR, Kidder LS, Sharma M, Bhattacharya M, Jackson S, Le C, Yee D.
    Calcif Tissue Int; 2012 Jan 01; 90(1):40-9. PubMed ID: 22083107
    [Abstract] [Full Text] [Related]

  • 6. Transient disturbance in physeal morphology is associated with long-term effects of nitrogen-containing bisphosphonates in growing rabbits.
    Smith EJ, Little DG, Briody JN, McEvoy A, Smith NC, Eisman JA, Gardiner EM.
    J Bone Miner Res; 2005 Oct 01; 20(10):1731-41. PubMed ID: 16160731
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Differential effect of doxorubicin and zoledronic acid on intraosseous versus extraosseous breast tumor growth in vivo.
    Ottewell PD, Deux B, Mönkkönen H, Cross S, Coleman RE, Clezardin P, Holen I.
    Clin Cancer Res; 2008 Jul 15; 14(14):4658-66. PubMed ID: 18628481
    [Abstract] [Full Text] [Related]

  • 9. Addition of bisphosphonate to antibiotic and anti-inflammatory treatment reduces bone resorption in experimental Staphylococcus aureus-induced arthritis.
    Verdrengh M, Carlsten H, Ohlsson C, Tarkowski A.
    J Orthop Res; 2007 Mar 15; 25(3):304-10. PubMed ID: 17089391
    [Abstract] [Full Text] [Related]

  • 10. A single intravenous administration of zoledronic acid prevents the bone loss and mechanical compromise induced by aromatase inhibition in rats.
    Gasser JA, Green JR, Shen V, Ingold P, Rebmann A, Bhatnagar AS, Evans DB.
    Bone; 2006 Oct 15; 39(4):787-95. PubMed ID: 16844441
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Zoledronic acid treatment of 5T2MM-bearing mice inhibits the development of myeloma bone disease: evidence for decreased osteolysis, tumor burden and angiogenesis, and increased survival.
    Croucher PI, De Hendrik R, Perry MJ, Hijzen A, Shipman CM, Lippitt J, Green J, Van Marck E, Van Camp B, Vanderkerken K.
    J Bone Miner Res; 2003 Mar 15; 18(3):482-92. PubMed ID: 12619933
    [Abstract] [Full Text] [Related]

  • 13. Temporal changes in bone mass and mechanical properties in a murine model of tumor osteolysis.
    Arrington SA, Schoonmaker JE, Damron TA, Mann KA, Allen MJ.
    Bone; 2006 Mar 15; 38(3):359-67. PubMed ID: 16278105
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Zoledronic acid prevents loss of trabecular bone after focal irradiation in mice.
    Keenawinna L, Oest ME, Mann KA, Spadaro J, Damron TA.
    Radiat Res; 2013 Jul 15; 180(1):89-99. PubMed ID: 23772924
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. No anti-angiogenic effect of clinical dosing regimens of a single zoledronic acid injection in an experimental bone healing site.
    Biver E, Vieillard MH, Cortet B, Salleron J, Falgayrac G, Penel G.
    Bone; 2010 Mar 15; 46(3):643-8. PubMed ID: 19895916
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Minodronic acid (ONO-5920/YM529) prevents decrease in bone mineral density and bone strength, and improves bone microarchitecture in ovariectomized cynomolgus monkeys.
    Mori H, Tanaka M, Kayasuga R, Masuda T, Ochi Y, Yamada H, Kishikawa K, Ito M, Nakamura T.
    Bone; 2008 Nov 15; 43(5):840-8. PubMed ID: 18718565
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.